| scholarly article | Q13442814 |
| P2093 | author name string | Hajime Kubo | |
| Kenneth B Margulies | |||
| Stephen A Douglas | |||
| Michael P Quaile | |||
| Carie L Kimbrough | |||
| P2860 | cites work | Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 |
| Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure | Q28177421 | ||
| Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators | Q28566263 | ||
| Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure | Q33199056 | ||
| Hormones and hemodynamics in heart failure | Q33713907 | ||
| Pathophysiology of chronic heart failure | Q34239875 | ||
| Cardiostimulant effects of urotensin-II in human heart in vitro | Q35043105 | ||
| Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II | Q35048941 | ||
| The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems | Q35100902 | ||
| Neurohormonal activation in congestive heart failure and the role of vasopressin | Q36104992 | ||
| Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications | Q36133997 | ||
| Effect of endothelins on the cardiovascular system | Q36576870 | ||
| Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey | Q42059806 | ||
| Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy | Q42169441 | ||
| Sex-based differences in myocardial contractile reserve | Q42502024 | ||
| Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance | Q43721249 | ||
| Congestive heart failure and expression of myocardial urotensin II. | Q44036542 | ||
| Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease | Q44047539 | ||
| Effects of urotensin II on isolated rat hearts under normal perfusion and ischemia reperfusion | Q44561032 | ||
| Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart | Q45015009 | ||
| Reduced sarcoplasmic reticulum Ca(2+) load mediates impaired contractile reserve in right ventricular pressure overload | Q46954786 | ||
| Contribution of reverse-mode sodium-calcium exchange to contractions in failing human left ventricular myocytes | Q48008656 | ||
| Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy | Q48010955 | ||
| The trabecula culture system: a novel technique to study contractile parameters over a multiday time period. | Q48014051 | ||
| Plasma urotensin in human systolic heart failure | Q48434734 | ||
| Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation. | Q53615834 | ||
| Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure | Q74696316 | ||
| Plasma urotensin II in heart failure | Q74811631 | ||
| Abnormal frequency-dependent responses represent the pathophysiologic signature of contractile failure in human myocardium | Q75301226 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 39-46 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Circulation: Heart Failure | Q2865806 |
| P1476 | title | Direct inotropic effects of exogenous and endogenous urotensin-II: divergent actions in failing and nonfailing human myocardium | |
| P478 | volume | 2 |
| Q57771763 | 1,3,4-Thiadiazol-2-amine Derivatives as Urotensin-II Receptor (UT) Antagonists |
| Q42070109 | A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart |
| Q46981255 | Contractile responses to rat urotensin II in resting and depolarized basilar arteries. |
| Q35680934 | Differential expression of PDE5 in failing and nonfailing human myocardium |
| Q34233981 | GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo |
| Q88287377 | The value of urotensin II in patients with left-sided rheumatic valvular regurgitation |
Search more.